HIV publications

  1. S. Chowdhury, P.K. Roy, R.J. Smith?, Mathematical modelling of enfuvirtide and protease inhibitors as combination therapy for HIV (International Journal of Nonlinear Sciences and Numerical Simulation, 2016, 17(6), 259-275)

  2. R.J. Smith?, B.Y. Lee, A. Moustakas, A. Zeigler, M. Prague, R. Santos, M. Chung, R. Gras, V. Forbes, S. Borg, T. Comans, Y. Ma, N. Punt, W. Jusko, L. Brotz, A. Hyder, Population Modelling by Examples II (Proceedings of the SummerSim-SCSC 2016 conference, 2016, 354-361)

  3. M. Al-arydah, R.J. Smith? Adding education to "test and treat": Can we overcome drug resistance? (Journal of Applied Mathematics, 2015, Article ID 781270, 19 pages).

  4. R.E. Miron, R.J. Smith?, Resistance to protease inhibitors in a model of HIV-1 infection with impulsive drug effects (Bulletin of Mathematical Biology, 2014, 76(1), 59-97).

  5. Y. Xiao, S. Tang, Y. Zhou, R.J. Smith?, J. Wu, N. Wang, Predicting an HIV/AIDS epidemic and measuring the effect of mobility in mainland China (Journal of Theoretical Biology, 2013, 317, 271-285).

  6. B.P. Konrad, N. Vaidya and R.J. Smith?, Modelling mutation to a cytotoxic T-lymphocyte HIV vaccine (Mathematical Population Studies, 2011, 18(2), 122-149).

  7. J. Lou and R.J. Smith?, Modelling the effects of adherence to the HIV fusion inhibitor enfuvirtide (Journal of Theoretical Biology 2011, 268, 1-13

  8. R.J. Smith?, J.T. Okano, J.S. Kahn, E.N. Bodine, and S. Blower, Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco (Science 2010, 327:5966, 697-701).

  9. R.E. Miron and R.J. Smith?, Modelling imperfect adherence to HIV induction therapy (BMC Infectious Diseases 2010, 10:6).

  10. R.J. Smith? and B.D. Aggarwala, HIV: the invisible epidemic of the United States healthcare system. (Social Theory and Health 2010, 8, 83-94).

  11. R.J. Smith?, J. Li, R. Gordon and J.M. Heffernan, Can we spend our way out of the AIDS epidemic? A World Halting AIDS Model (BMC Public Health 2009, 9(Suppl 1):S15).

  12. R. Gordon, N.K. Bjorklund, R.J. Smith? and E.R. Blyden, Halting HIV/AIDS with Avatars and Havatars (BMC Public Health 2009, 9(Suppl 1):S13).

  13. R.J. Smith?, R. Gordon, The OptAIDS Project: Towards global halting of HIV/AIDS (BMC Public Health 2009, 9(Suppl 1):S1).

  14. R.J. Smith? and B.D. Aggarwala, Can the viral reservoir of latently infected CD4+ T cells be eradicated with antiretroviral HIV drugs? (Journal of Mathematical Biology 2009, 59, 697-715).

  15. B.P. Konrad, R.J. Smith? and F.L. Lutscher, Gender differences in heterosexual transmission of HIV in urban and rural populations (Advances in Disease Epidemiology 2009, in: J.M. Tchuenche and Z. Mukandavire, eds, pp31-57).

  16. B.D. Aggarwala and R.J. Smith? Do frequent doses of HAART block the HIV blips? (Far East Journal of Mathematical Sciences 2009, 32:2, 231-251).

  17. R.J. Smith?, E.J. Schwartz, Predicting the potential impact of a cytotoxic T-lymphocyte HIV vaccine: how often should you vaccinate and how strong should the vaccine be? (Mathematical Biosciences 2008, 212, 180-187).

  18. R.J. Smith? Explicitly accounting for antiretroviral drug uptake in theoretical HIV models predicts long-term failure of protease-only therapy (Journal of Theoretical Biology 2008, 251(2), 227-237).

  19. R.J. Smith?, S. Magnet, The impact of vaginal microbicides must also target men (Journal of Men's Health & Gender 2007, 4(1), 81-84).

  20. R.J. Smith, Adherence to antiretroviral HIV drugs: how many doses can you miss before resistance emerges? (Proceedings of the Royal Society of London Series B: Biological Sciences, Vol 273 No 1586 2006 pp 617-624).

  21. D.P. Wilson, E.N. Bodine, R.J. Smith and S.M. Blower, Response to Foss et al., 'Care should be taken when promoting microbicide use among sex workers who are able to use condoms consistently' (AIDS 2005, 19:17, 2044-46).

  22. R.J. Smith, E. Bodine, D. Wilson and S.M. Blower, Evaluating the potential impact of vaginal microbicides in reducing the risk of HIV acquisition in female sex workers (AIDS, Vol 19 2005 pp 423-431).

  23. S.M. Blower and R.J. Smith, Is population-level perversity a likely outcome of mass vaccination against HIV? - Authors' reply. (The Lancet Infectious Diseases, Vol 5 2005 255-256).

  24. R.J. Smith and L.M. Wahl, Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects (The Bulletin of Mathematical Biology, Vol 67:4 2005 pp 783-813).

  25. R.J. Smith and S.M. Blower, Could disease-modifying HIV vaccines cause population-level perversity? (The Lancet Infectious Diseases, Vol 4 2004 pp 636-639).

  26. R.J. Smith and L.M. Wahl, Distinct effects of protease and reverse transcriptase inhibition in an immunological model of HIV-1 infection with impulsive drug effects (The Bulletin of Mathematical Biology, Vol 66:5 2004 pp 1259-1283).